|
Volumn 167, Issue 4, 2012, Pages 949-951
|
Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: Efficacy in severe acral psoriasis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALITRETINOIN;
CORTICOSTEROID;
CYCLOSPORIN A;
ETRETIN;
FUMARIC ACID ETHYL ESTER;
INFLIXIMAB;
METHOTREXATE;
PSORALEN;
ACRAL PSORIASIS;
ADD ON THERAPY;
DIFFERENTIAL DIAGNOSIS;
DISEASE SEVERITY;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DRY LIP;
ERYTHEMA;
FATIGUE;
HUMAN;
LETTER;
LIP DISEASE;
LIP FISSURE;
MONOTHERAPY;
ONYCHOLYSIS;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PSORIASIS;
QUALITY OF LIFE;
SCORING SYSTEM;
TREATMENT DURATION;
TREATMENT RESPONSE;
ULTRAVIOLET A RADIATION;
ACITRETIN;
ADOLESCENT;
ANTIBODIES, MONOCLONAL;
DERMATOLOGIC AGENTS;
DRUG THERAPY, COMBINATION;
HUMANS;
MALE;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TRETINOIN;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84867052270
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.2012.10983.x Document Type: Letter |
Times cited : (4)
|
References (6)
|